MEN1 was originally identified as a tumour suppressor, and mutations of the MEN1 in humans have been associated with various endocrine tumours, including parathyroid hyperplasia, pituitary adenomas and islet cell tumours.11, 12. This evidence concerns the gene MEN1 and neoplasm.